Ann Arbor, MI

– Swift Biosciences and Daicel Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology within the Swift RNA Library Kits combined with myBaits technology from Daicel Arbor Biosciences for hybridization-based target enrichment of the virus for whole genome sequencing.

“We are very pleased to partner with our local colleagues in Ann Arbor, to synergize Swift’s library prep technology with Arbor’s myBaits capture technology”, said Drew McUsic, Ph.D., Swift’s Director of Product Management. “As research and public health labs continue to study mutation profiles of the virus across thousands of collected specimens, our collaboration puts a high performing NGS workflow in their hands to efficiently prepare samples for analysis, even when heavily degraded or otherwise incompatible with PCR-based approaches.”

Hybridization-based target enrichment can retrieve target sequences that have significant genomic rearrangements or mutations relative to the reference used for probe or primer design. This allows the Swift and Arbor workflow to be robust to structural nucleotide variants segregating within the SARS-CoV-2 population.

“We have been providing the SARS-CoV-2 panel free of charge to research labs studying the evolution of the novel coronavirus and are excited to partner with Swift Biosciences on this effort,” stated Alison Devault, Director of Genomics at Daicel Arbor Biosciences. “Detection of viral mutations is heavily reliant on sample preparation prior to sequencing and Swift’s RNA library prep meets the sensitivity required for this virus.”

The two companies’ combined product offering includes modules for RNA fragmentation and reverse transcription, library preparation and amplification, indexed adapters, capture probes, blockers, and wash buffers for SARS-CoV-2 enrichment. No ribosomal RNA depletion or other enrichment or depletion steps are required. Customers in North America may purchase the full set of reagents directly from either Swift or from Daicel Arbor Biosciences.

About Swift Biosciences

Swift Biosciences, based in Ann Arbor, Michigan, develops enabling technologies for genomics, translational and clinical research. Swift’s technologies expand the range of sample inputs to broaden applications of next-generation sequencing (NGS). The company has developed unique intellectual property (IP) to enhance adapter ligation to both single and double-stranded DNA, improve multiplexed PCR for targeted sequencing, and enable novel solutions for NGS workflows. Swift’s new RNA Library Kits are the fastest on the market and powered by Swift’s Adaptase® technology, which allows stranded RNA library construction directly from first-strand cDNA.

Swift’s portfolio enables new applications in multiple industries, including agrigenomics, pharmaceutical, academic, biotechnology, and oncology research fields. All products are for research use only. For more information, visit and follow Swift Biosciences on Twitter (@SwiftBioSci).

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications. For more information, visit http://www.arborbiosci.com/ and follow Daicel Arbor Biosciences on Twitter (@ArborBio).

Download a pdf of the press release.

For more information on Daicel Arbor Biosciences, contact:

Michele Gentile

Daicel Arbor Biosciences

For more information, contact:

Camille Cappello
Swift Biosciences
cappello@swiftbio.com

Tokyo, Japan & Ann Arbor, MI

DAICEL Corporation, the parent company of Daicel Arbor Biosciences, is providing their innovative drug delivery device, pyro-drive jet injector ActranzaTM lab., for use in a joint partnership to develop a DNA vaccine against SARS-CoV-2, currently being conducted by Osaka University and Japanese company AnGes, Inc.

Overview of the Joint Partnership

  • An effort is underway for the development of a prophylactic DNA vaccine for the SARS-CoV-2 virus between Osaka University (Department of Clinical Gene Therapy/Department of Health Development and Medicine), and AnGes. Inc., utilizing AnGes, Inc.’s plasmid DNA platform.
  • The DNA vaccine production process is generally established in a shorter period of time than the production of conventional vaccines, and is being performed by Takara Bio Inc., who has the plasmid DNA production technology and facilities.
  • DAICEL has developed a gene transfer method using the ActranzaTM device, and is conducting research for its clinical application with Osaka University (Department of Device Application for Molecular Therapeutics/Department of Health Development and Medicine). This technology enables efficient delivery of plasmid DNA encoding antigen protein directly into cells via intradermal delivery, in order to initiate antibody production in the body.

About DNA Vaccines

DNA vaccines can be produced in a short period of time without pathogenic components. By inoculating a person with DNA plasmid encoding for a specific viral protein of the pathogen, the antigen protein is produced in the body without effects of the virus, while generating an immune response and thus further immunity against the pathogen.

About the Novel Drug Delivery Device ActranzaTM lab.

Actranza™ lab. is a needle-free, jet injector driven by the instantaneous power generated from pyro combustion.
The high-speed stream of liquid ejected by the device, such as a DNA vaccine, penetrates the skin and disperses directly into intradermal tissue. Because intradermal tissue contains more immunocompetent cells than muscle tissue, animal studies have shown that higher gene expression can be achieved when DNA vaccines are delivered intradermally when compared to intramuscular delivery with conventional needle injections. View details: https://www.daicel.com/en/research/actranza.html

To learn more about ActranzaTM lab. contact:

Fabien Rousset Ph.D

US Representative for Actranza™ lab. from Daicel Corporation

Office: +33 (0) 3 88 79 52 00

Cell: +33 (0) 7 88 83 69 20

Email: frousset@cte.daicel.com

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

Download a pdf of the press release.

Ann Arbor, MI

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and leader in developing molecular biology research tools, today announced the release of a myBaits Expert hybridization-based panel for the 2019 Novel Coronavirus (2019-nCoV). The next-generation sequencing panel is for research use only, and will be offered free of charge to global researchers working to help identify the source organism and evolution of the virus.

Leveraging their expertise in designing and manufacturing high performance NGS enrichment panels for pathogens, Daicel Arbor Biosciences produced the new 2019-nCoV panel in just one week following a request from the research community. To aid in urgent research on this global threat, Arbor will provide complete 2019-nCoV hybridization capture kits free of charge to researchers worldwide who are studying the epidemiological and phylogenetic properties of this novel virus.

“After receiving the initial request for a 2019-nCoV panel, the urgency of the situation made it clear that we should make comprehensive study kits available as quickly as possible to all members of the virology research community”, stated Alison Devault, Director of Genomics at Daicel Arbor Biosciences. “As agencies work to contain the spread of the virus, the Arbor team is honored to provide any resources that we can to aid researchers in studying the evolution of this new pathogen. Our thoughts continue to be with all the healthcare workers, researchers, and victims of the tragic COVID-19 outbreak.”

The myBaits Expert 2019-nCoV panel is based on all full and partial genome sequences available in the NCBI database as of January 31, 2020. Arbor is actively accepting requests for the panel, which is available for immediate shipment, on their website and through email.

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

Contact for Daicel Arbor Biosciences:
Michele Gentile
mgentile@arbor.daicel.com

LGC Biosearch Logo       

Ann Arbor, MI

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and worldwide leader in next generation sequencing (NGS) target enrichment, today announced a partnership with Biosearch Technologies, the complete genomics portfolio of LGC Group. LGC Group was founded over 175 years ago, and today supplies products and services in the life sciences sector to improve human healthcare, agri-food technology, and the environment across the world. Together, the organizations will use their extensive resources for genetic testing and marker discovery to deliver custom sequencing solutions to the agrigenomics market.

Through the partnership, Biosearch Technologies will become the exclusive global provider of custom hybridization-based targeted sequencing oligonucleotide panels powered by myBaits technology to commercial agricultural organizations and seed breeding companies. Daicel Arbor Biosciences will maintain their strong presence in academic and government research laboratories by continuing to serve these researchers with catalog and custom panels. Overall, the partnership will allow Biosearch Technologies to leverage their established relationships with commercial organizations by delivering a complimentary technology necessary for marker discovery in crop sciences.

Alison Devault, Director of Genomics at Daicel Arbor Biosciences stated “Custom hybridization capture kits for targeted NGS have been our speciality for almost a decade, and perfectly complement LGC Biosearch’s robust expertise with genotyping assays for commercial ag-bio applications. We are truly excited for this partnership that will allow both parties to better serve key clients and provide innovative, complete NGS solutions for the entire ag-bio genomics market.”

Mark Dearden, VP of Strategy and Marketing at LGC, Biosearch Technologies commented “The addition of custom hybridization-based targeted sequencing panels to our portfolio adds a critical component to our NGS offering for the AgBio sector..  We are excited about taking this next step with Daicel Arbor Biosciences and will continue to invest to support our customer’s  mission critical applications.”

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and a subsidiary of Daicel Corporation, is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About LGC Biosearch Technologies

LGC is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment. LGC provides a comprehensive range of reference materials, proficiency testing schemes, and genomics reagents​, as well as research and measurement services. Its scientific tools and solutions enable organisations to advance research, develop new products and form an essential part of their quality and compliance procedures.

LGC’s 3,150 employees include internationally-recognised scientists who are experts in their field. Headquartered in London, it operates out of 19 countries worldwide and is extensively accredited to quality standards such as GMP, GLP, ISO 13485, ISO 17034, ISO 17043, ISO/IEC 17025 and ISO 9001.

LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC has been privately-owned since 1996 and has diversified through internal investment and acquisition to be an international leader in its chosen markets. LGC is now owned by funds affiliated with KKR.

For more information, please visit www.lgcgroup.com

Contact for Daicel Arbor Biosciences:
Michele Gentile
Daicel Arbor Biosciences

Contact for LGC, Biosearch Technologies:
Julian Quigley
LGC
Julian.quigley@lgcgroup.com
+44 20 8943 8491

Curio Logo

San Diego, California

Arbor Bioscience and Curio Genomics announced an exciting expansion of their existing partnership today at the 28th International Plant and Animal Genome conference in San Diego. The enhanced partnership promises to deliver a host of additional first-in-class products and solutions to the plant research and development community in commercial, as well as, non-profit foundations, consortia, and academic institutions.

With a potential deal value exceeding $1 million, the multiyear partnership leverages the core expertise and experience of each company to deliver cutting-edge, robust and comprehensive products for customers. Daicel Arbor Biosciences brings decades of combined expertise in NGS with novel advanced synthesis chemistry and expert scientific consulting to develop both catalog and custom targeted sequencing panels. Curio Genomics brings decades of experience in big-data commercial software platforms designed from the beginning for limitless scalability and extensibility, essential for genomic research with larger data sets, new types, and greater demand to integrative analyses each year.

“This is a transformative partnership for Curio,” said David Brabec, Curio’s Chief Business Officer. “We know that researchers, both commercial and academic, want and need solutions that are continuously cutting-edge, if we are going to continue feeding a growing world in a time when our climate is rapidly changing. Daicel Arbor Biosciences’ decades of combined scientific expertise in NGS and their track record of delighted customers was a key for us choosing them as our first major partner.”

“Curio is the perfect partner as we continue to expand Arbor’s solutions to enhance and simplify research for our customers,” said Arbor Bioscience’s Director of Genomics, Alison Devault. “The plant genomics space is an incredibly exciting business opportunity, but also a truly meaningful research space for translational and social impact. We are proud to be making such a visible commitment to this important and adapting market.”

Product Roadmap

The companies’ announcement included immediate plans to expand their existing and acclaimed wheat exome and complete genome analysis solution by fully integrating their current offerings by mid-2020 with new capabilities for wheat researchers, such assupport for RNA-Seq and methylation analysis, to be released later in 2020, and over the course of the multiyear partnership. The companies also announced immediate plans to co-develop products for additional species beyond wheat and will disclose these product plans at a later date.

“With Arbor’s decades of combined experience in NGS, we will leverage the power of the Curio® platform to provide whole genomic research teams a collaborative and endlessly extensible environment for real-time processing, analysis and interpretation of plant genomic data,” said Curio’s co-founder and CTO, Shawn Quinn. “We are excited to provide complete solutions for researchers from question to sample to insight and back again.”

###

About Daicel Arbor Biosciences, Inc.

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and a subsidiary of Daicel Corporation, is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About Curio Genomics

Curio Genomics leverages its decades of big data commercial software development experience to provide the robust, rapidly extensible bioinformatics platform called Curio™. The guiding principle of Curio Genomics is that software should facilitate genomic research, not consume it. Through fully integrated partnerships with Next-Gen Sequencing leaders, Curio provides powerful, first-in-class product solutions that empower researchers from sample-to-insight. For information about Curio Genomics unique bioinformatics software platform, visit www.curiogenomics.com

Contact for Daicel Arbor Biosciences:

Michele Gentile
mgentile@arbor.daicel.com

Contact for Curio Genomics:

David Brabec
Curio Genomics
dbrabec@moxiegenomics.com
+1 734 726 7581

New myTXTL bulk packaging align with volumes required for high-throughput organizations in synthetic biology.

Ann Arbor, MI

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and leader in developing molecular biology research tools, today announced the launch of myTXTL® bulk pack sizes while attending the SynBioBeta 2019 conference in San Francisco, CA, as an addition to their growing catalog of cell-free expression kits for synthetic biology applications. This new offering aligns with the growing demand for larger volume requirements by organizations utilizing high-throughput screening in protein and enzyme engineering. The pack sizes and aliquots of the master mixes are ideal for cell-free expression on automated liquid handling systems.

Cell-free expression systems are currently available from Daicel Arbor Biosciences as a Sigma 70 or a linear DNA expression master mix. Both systems use E. coli as a base lysate combined with amino acids, essential elements, and a regenerative energy buffer in a complete, simple to use master mix which only requires the addition of template DNA. The Sigma 70 system relies on circular or plasmid DNA while the linear system can transcribe circularized or linear DNA as a template prior to translation. Either system will be available to researchers in bulk format to pair with their high-throughput DNA template generation systems.

“The uses of cell-free expression systems continue to expand in synthetic biology and we want to stay aligned with our client base as they scale their discovery pipelines”, stated Evelyn Eggenstein Ph.D., Synthetic Biology Division Manager at Daicel Arbor Biosciences. “The rapid design- build-test cycle provided by myTXTL systems has accelerated discovery, especially when paired with linear DNA templates.”

The Sigma 70 and Linear DNA Expression Master Mixes are available for immediate order in 5, 10, and 25 mL sizes with a lead time of 3 – 4 weeks for shipment. Daicel Arbor Biosciences is also working with organizations on custom pack sizes greater than 25 mL and aliquot sizes to match end-user requirements. Introductory pricing will be available on bulk pack sizes at the SynBioBeta conference and through the end of the year.

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and a subsidiary of Daicel Corporation, is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications.We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About Chiral Technologies

Chiral Technologies, a subsidiary of DAICEL CORPORATION, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into singleenantiomers. The company also provides analytical method development and custom separation services. Learn more at www.chiraltech.com.

Contact for Daicel Arbor Biosciences:

Michele Gentile

mgentile@arbor.daicel.com

Daicel Arbor Biosciences is proud to provide sponsorship to ten teams participating in the 2019 iGEM competition with myTXTL®Cell-Free Expression kit and myNGS Guides guide RNA pools for their projects. The company will be participating in the Giant Jamboree in Boston, MA on October 31 – November 3, 2019. Learn more.

Ann Arbor, MI

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome. Arbor has an ongoing collaboration with the International Wheat Genome Sequencing Consortium (IWGSC), an international organization dedicated to developing a gold-standard reference genome for bread wheat cv. Chinese Spring, to provide IWGSC members with a standardized exome panel for research and development. Adding the Curio Genomics strategic partnership allows Daicel Arbor Biosciences to harness the power of the Curio Genomics platform in an end-to-end solution, from DNA to variant analysis, for wheat exome sequencing through their myReads® NGS services division.

The Curio Genomics platform streamlines bioinformatics analysis by moving beyond the typical pipeline approach of serial processes through parallel processing sequencing data. Curio’s ability to bring together both analytical processing and data visualization into a common toolset allows researchers to experiment and ask questions of the data in a very fluid fashion. Curio’s unique incremental and parallel approach to processing wheat exome samples allows users to compare, change analytical settings and, apply different filters all in real time with the results immediately at their fingertips.

“We are excited to partner with Daicel Arbor Biosciences and expand our genomics portfolio to include wheat and other agricultural crops.” stated David Brabec, Partner at Moxie Genomics (the company behind the Curio Genomics platform). “Our on-premise system is designed for large scale breeding organizations while our cloud-based solution delivers immediate access to wheat researchers across the globe”

Sequencing and analysis of the entire bread wheat genome is incredibly difficult and costly due to its enormous size, complex sub-genomes, and more than 85% of the genome being composed of repetitive elements. Daicel Arbor Biosciences initially reduced sequencing costs of each sample with the myBaits® Expert Wheat Exome capture panel the high-confidence exon-annotated genome in hexaploid wheat the resulting data with Curio’s platform.

“The IWGSC is committed to ensuring that the wheat breeders have state-of-the-art genomic resources. In this partnership, our members as well as the scientific community will benefit from having access to a unified analysis platform which streamlines data sharing and can facilitate comparative analyses across the consortium,” said Kellye Eversole, Executive Director of the IWGSC.

Daicel Arbor Biosciences is launching the full-service offering this month which includes the myBaitsÒ Expert Wheat Exome capture panel and Curio Genomics bioinformatics analysis through the myReads NGS services or as stand-alone products. The bioinformatics service provides whole genome alignment as well as variant calling from Chinese Spring or other cultivars of hexaploid wheat. Daicel Arbor Biosciences’ partnership with the IWGSC and Curio Genomics will continue as Arbor plans to develop new iterations of the exome panel and data analysis pipeline as further understanding of the wheat genome grows. Additionally, Daicel Arbor Biosciences is developing panels specific to disease and drought resistance for wheat researchers.

“The Curio platform delivers rapid processing of data in a user-friendly interface for our clients.” explained Jacob Enk, PhD, Senior Scientist at Daicel Arbor Biosciences. “We are proud to add this high-performance solution for IWGSC members and the wheat research community.”

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc. and a subsidiary of Daicel Corporation, is a development and manufacturing company founded by scientists to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About Curio Genomics

Curio Genomics’ proprietary parallelized bioinformatics platform enables unprecedented data processing speed. Intuitive and easy to use interfaces allow researchers to ask simple and complex questions simultaneously as the data is being processed providing extensive analytic versatility and power. This unique approach also allows complex questions to be asked across multiple samples and data sets, making it possible to share, query, annotate and comment on data in real time, empowering collaboration and distributed research. For information about Curio Genomics bioinformatics tools, visit www.curiogenomics.com

About the International Wheat Genome Sequencing Consortium

The IWGSC, with 2,400 members in 68 countries, is an international, collaborative consortium, established in 2005 by a group of wheat growers, plant scientists, and public and private breeders. The goal of the IWGSC is to make a high-quality genome sequence of bread wheat publicly available, in order to lay a foundation for basic research that will enable breeders to develop improved varieties. The IWGSC is a U.S. 501(c)(3) non-profit organization. www.wheatgenome.org

Contact for Daicel Arbor Biosciences:

Michele Gentile – Updated 1.18.21

mgentile@arbor.daicel.com

Contact for the IWGSC:page2image173303536

Isabelle Caugantpage2image173306032

IWGSC Communications Directorpage2image173309872

communications@wheatgenome.orgpage2image173313744

+1 916 840 8801

Twitter: @wheatgenome

Contact for Curio Genomics:

David Brabec

Moxie Genomics, Inc.
+1 734 726 7581

dbrabec@moxiegenomics.com

Ann Arbor, MI

Daicel Arbor Biosciences, a worldwide leader in next generation sequencing (NGS) target enrichment and synthetic biology, announces their partnership with the International Wheat Genome Sequencing Consortium (IWGSC), an international organization dedicated to developing a gold-standard reference genome for bread wheat cv. Chinese Spring. This strategic partnership will provide IWGSC members with a standardized exome panel for research and development as well as expand Arbor’s collaboratively developed myBaitsÒ Expert panels in agrigenomics.

“Our members have been working together since 2005 to generate a gold-standard reference genome for Chinese Spring.” said Kellye Eversole, Executive Director of the IWGSC. “Partnering with Daicel Arbor Biosciences will accelerate research efforts into the inner-workings of this very complex genome.”

Sequencing the bread wheat genome was an incredible feat, due to its enormous size – five times larger than the human genome – and complexity – bread wheat has three sub-genomes and more than 85% of the genome is composed of repeated elements. The potential to analyze only the exome, or just the functionally expressed genes, greatly reduces the cost of sequencing each sample and speeds analysis of the resulting data.

Daicel Arbor Biosciences is launching the initial myBaits® Expert Wheat Exome capture panel at the International Plant and Animal Genome Conference in San Diego, CA, USA based on the complete high-confidence exon-annotated genome in hexaploid wheat. The partnership with the IWGSC and its members will continue as Arbor plans to develop new iterations of the exome panel with further understanding of the genome as well as panels specific to disease and drought resistance. Additionally, Daicel Arbor Biosciences is developing a robust bioinformatics pipeline of the exome in order to streamline data analysis and deliver consistency across the consortium.

“We are proud to develop this wheat exome panel, which can be paired with any library preparation, in conjunction with the IWGSC.” explained Jacob Enk, PhD, Senior Scientist at Daicel Arbor Biosciences. “The panel will be added to our targeted sequencing services offering for researchers who require a complete solution from DNA to data analysis.”

The reference sequence for Chinese Spring was made available to the scientific community in January 2017 and an analysis of the reference sequence was published in the journal Science in August 2018. Since the beginning of 2018, more than 250 publications have been published using this resource, yet only a portion of the genome has been manually or functionally annotated with high confidence. Daicel Arbor Biosciences and the IWGSC will continue to collaborate with consortium members as well as outside breeders, plant scientists and wheat growers to further define the genome and develop new resources for studying this valuable crop.

###

About Daicel Arbor Biosciences

Daicel Arbor Biosciences is a development and manufacturing company owned by scientists founded to serve our peers in molecular biology applications. We are a passionate organization of scientists determined to deliver cost-effective, user-friendly products to researchers of genetics and synthetic biology. The team at Daicel Arbor Biosciences prides themselves on providing exceptional customer service and timely technical support to new or advanced users on our array of products. We routinely collaborate with our customers and research partners to develop innovative solutions to address their unique applications.

About the International Wheat Genome Sequencing Consortium

The IWGSC, with 2,400 members in 68 countries, is an international, collaborative consortium, established in 2005 by a group of wheat growers, plant scientists, and public and private breeders. The goal of the IWGSC is to make a high-quality genome sequence of bread wheat publicly available, in order to lay a foundation for basic research that will enable breeders to develop improved varieties. The IWGSC is a U.S. 501(c)(3) non-profit organization. www.wheatgenome.org

Contact for Daicel Arbor Biosciences (updated 1.18.21):
Michele Gentile
Daicel Arbor Biosciences
mgentile@arbor.daicel.com

Contact for the IWGSC:
Isabelle Caugant
IWGSC Communications Director
communications@wheatgenome.org
+1 916 840 8801
Twitter: @wheatgenome